 safety efficacy evaluation fibrel correction cutaneous scars treatments erratum Dermatol Surg Oncol Aug multicenter clinical trial patients Fibrel weeks negative skin test correction cutaneous scars Fibrel treatment implants maximum scars scar corrections physician patient objective photogrammetric method end year percentage scars moderate marked complete correction physician patient photogrammetric evaluations cohort patients years patients years postimplantation physician patient evaluations scars moderate marked complete correction category end years treatments Safety evaluations tests antinuclear antibodies rheumatoid factor presence antibodies Fibrel crossreactivity human collagen III tests causal relationship Fibrel treatments patients untoward immunologic symptoms data patients treatments effective correction depressed cutaneous scars years negligible adverse sequelae untoward immunologic symptoms